Posts by Grace Yang
The '156 patent discloses methods of treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication …
Grace Yang focuses her practice on intellectual property litigation in biotechnology, pharmaceuticals, including Hatch-Waxman suits, and medical devices, and intellectual property due diligence. She has worked on matters spanning a wide range of technical fields, such as oncology, neurology, genetics, and immunology. Grace received her J.D. from Fordham University School of Law and her Ph.D. in Organic Chemistry from University of California, San Diego. Her doctoral research was based on developing synthetic aminoglycosidic antibiotics that inhibit bacteria’s ability to synthesize protein by interfering with the binding of aminoacyl-tRNA to the bacterial ribosome 30S subunit. For more information, or to contact Grace, please visit her firm profile page.